Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
November 08, 2025 11:45 ET | Source: Vor Biopharma Treatment with telitacicept…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
Marriott India strengthens the Green Commitment on World Environment Day 2025
Achieves Milestone of Planting 100,000 Trees BENGALURU, India, June 5, 2025 /PRNewswire/…
Godrej Consumer Products Achieves Global Sustainability Milestone, Ranks Among Top 3 FMCG Companies Globally on Dow Jones Sustainability Index 2024
MUMBAI, India, Dec. 20, 2024 /PRNewswire/ -- Godrej Consumer Products Limited (GCPL),…
Innovation in Abu Dhabi: The Venom Blockchain Revolution Begins
ABU DHABI, UAE, April 9, 2024 /CNW/ -- Marking a milestone in the technology…
